Most Clicked StoriesMore >


Sanofi gains FDA approval for diabetes drug

DiabetesPro SmartBrief | Feb 26, 2015

Sanofi received federal approval for its long-acting basal insulin Toujeo for the treatment of patients with type 1 or type 2 diabetes. Reuters (02/25)


Heavy breakfast, light dinner approach improves blood glucose control

DiabetesPro SmartBrief | Feb 26, 2015

Study: Exercise, metformin may reduce type 2 diabetes risk after GDM

DiabetesPro SmartBrief | Feb 24, 2015

Study: Fetal sex may play role in gestational diabetes risk

DiabetesPro SmartBrief | Feb 23, 2015

Low vitamin D may be tied to higher diabetes risk

DiabetesPro SmartBrief | Feb 25, 2015

MRI technique may help detect inflammation in diabetes patients

DiabetesPro SmartBrief | Feb 20, 2015

ADA names Kevin Hagan as new CEO

DiabetesPro SmartBrief | Feb 25, 2015

Study: Drug cuts liver triglyceride, fasting glucose levels in diabetes

DiabetesPro SmartBrief | Feb 25, 2015

Health literacy levels could affect perception of diabetes control

DiabetesPro SmartBrief | Feb 23, 2015

Study looks at how sleep deprivation increases diabetes risk

DiabetesPro SmartBrief | Feb 20, 2015


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


My Health Advisor

DiabetesPro SmartBrief | Feb 27, 2015

Pathway to Stop Diabetes Call for Nominations

DiabetesPro SmartBrief | Feb 26, 2015

Continuing education for health care professionals who treat patients with diabetes

DiabetesPro SmartBrief | Feb 25, 2015

Association-funded research database

DiabetesPro SmartBrief | Feb 24, 2015

Core Research Program 2015 Call for Applications

DiabetesPro SmartBrief | Feb 23, 2015




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.